Replies to post #17614 on Synaptogenix Inc (SNPX)

[Cyosol]

Probably just more details about the last trial. Maybe highlighting the fact that patients beat placebo in the last trial when adjusting for baseline imbalance.

We've known that since last year though, so it's really just them giving investors a more detailed look at the data.